Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition

Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition

This study aimed to develop a computed tomography (CT)-based radiomics model capable of precisely predicting hyperprogression and pseudoprogression (PP) in patients with non-small cell lung cancer (NSCLC) treated with immunotherapy. We retrospectively analyzed 105 patients with NSCLC, from three ins...

Полное описание

Библиографические подробности
Главные авторы: Yikun Li, Peiliang Wang, Junhao Xu, Xiaonan Shi, Tianwen Yin, Feifei Teng
Формат: Статья
Язык:English
Опубликовано: Taylor & Francis Group 2024-12-01
Серии:OncoImmunology
Предметы:
Computed tomography
hyperprogression
immunotherapy
non-small cell lung cancer
pseudoprogression
radiomics
Online-ссылка:https://www.tandfonline.com/doi/10.1080/2162402X.2024.2312628

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2024.2312628

Схожие документы